GLAUCOMA RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$16,545,749
Receivables (Non-Related)
38%
Other Assets
24%
Cash & Equivalents
21%
Investments
16%
Prepaid Expenses
<1%
Inventories
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Liabilities in 2025 (Year End)
$1,459,454
Grants Payable
51%
Other Liabilities
26%
Payables & Accruals
22%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$3,643,453
$3,497,922
-4%
Receivables (Non-Related)
$3,640,865
$6,210,928
+71%
Related-Party Receivables
$0
$0
-
Inventories
$31,480
$31,876
+1%
Prepaid Expenses
$167,026
$162,566
-3%
Investments
$3,343,804
$2,635,867
-21%
Property, Plant, & Equipment (net)
$243,825
$2,334
-99%
Other Assets
$3,568,124
$4,004,256
+12%
Total Assets
$14,638,577
$16,545,749
+13%
Liabilities
2024
2025
Change
Payables & Accruals
$164,869
$327,178
+98%
Grants Payable
$775,000
$747,500
-4%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$164,786
$384,776
+134%
Total Liabilities
$1,104,655
$1,459,454
+32%
Net assets
2024
2025
Change
Restricted Net Assets
$7,540,521
$9,966,174
+32%
Unrestricted Net Assets
$5,993,401
$5,120,121
-15%
Net assets
2024
2025
Change
Net assets
+$13,533,922
+$15,086,295
+11%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)